Frustration grows over wait on OxyContin maker’s settlement
More than a year after OxyContin maker Purdue Pharma reached a tentative settlement over the toll of opioids that was accepted nearly universally by the groups suing the company — including thousands of people injured by the drug — money is still not rolling out.
Start Free AccountGet access to 7 premium stories every month for FREE!
Already a Subscriber?Current print subscriber? Activate your complimentary Digital account.
Subscribe NowChoose a package that suits your preferences.